Please assess the completion status of the following clinical trial:

Trial Title: Duloxetine for the Treatment of Dysthymia

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria::~* Sign an informed consent form~* 18 years of age or older~* Females not pregnant or breastfeeding or planning pregnancy and using an acceptable form of contraception~* Meet DSM-IV criteria for dysthymia~* A screening IDS-C score of 17 or greater~* No history of serious or unstable medical disorder~* Not taking any significant concurrent medications~* Not currently receiving psychotherapy Exclusion Criteria:- Suffering from DSM-IV defined~* delirium, dementia, amnestic, or other cognitive disorders~* mental disorders due to a general medical condition~* factitious or somatoform disorders~* mental retardation or developmental disabilities~* substance or alcohol abuse within the last 3 months~* depressive disorders with current suicidal risk~* psychotic disorders including delusional disorder, somatic type~* dissociative disorder~* personality disorders sufficiently severe to interfere with study participation~* History of DSM-IV defined bipolar I or II disorder~* History of non-response of dysthymia to adequate antidepressant medication~* History of major depression refractory to two adequate trials of antidepressants

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).